Cabaletta Bio Inc
CABA1.480USD
+0.040+2.78%
交易中 （美东）报价延迟15分钟
75.10M总市值
亏损市盈率 TTM
关于 Cabaletta Bio Inc 公司
Cabaletta Bio, Inc. 是一家临床阶段的生物技术公司。该公司专注于发现和开发工程化 T 细胞疗法，这些疗法有可能通过一次性给药为自身免疫性疾病患者提供深度和持久的、甚至治愈性的反应。其 Cabaletta B 细胞消融方法 (CABA) 平台包含两种策略：自身免疫嵌合抗原受体 T 细胞 (CARTA) 和嵌合自身抗体受体 T 细胞 (CAART)。CABA-201 是其 CARTA 平台的主要候选产品，是一种含有 4-1BB 共刺激结构域的全人 CD19-CAR T 构建体，旨在治疗患有一系列自身免疫性疾病的患者。其 DSG3-CAART 候选产品正在第 1 阶段 DesCAARTes TM 试验中接受评估，用于治疗 mPV，一种影响粘膜上皮的 PV 亚型。其 MuSK-CAART 候选产品旨在治疗一组 MG 患者，针对自身反应性 B 细胞。
公司简介
公司代码CABA
公司名称Cabaletta Bio Inc
上市日期Oct 25, 2019
CEODr. Steven Nichtberger, M.D.
员工数量161
证券类型Ordinary Share
年结日Oct 25
公司地址2929 Arch Street
城市PHILADELPHIA
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编19104
电话12677593100
网址https://www.cabalettabio.com/
公司代码CABA
上市日期Oct 25, 2019
CEODr. Steven Nichtberger, M.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Steven Nichtberger, M.D.
Dr. Steven Nichtberger, M.D.
Chief Executive Officer, President, Chairman of the Board, Co-Founder
Chief Executive Officer, President, Chairman of the Board, Co-Founder
1.35M
-30.78%
Dr. Scott C. Brun, M.D.
Dr. Scott C. Brun, M.D.
Independent Director
Independent Director
--
--
Dr. David J. Chang, M.D.
Dr. David J. Chang, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Catherine Bollard, M.D.
Dr. Catherine Bollard, M.D.
Independent Director
Independent Director
--
--
Mr. Mark J. Simon
Mr. Mark J. Simon
Independent Director
Independent Director
--
--
Ms. Shawn Cline Tomasello
Ms. Shawn Cline Tomasello
Independent Director
Independent Director
--
--
Mr. Richard Conover Henriques, Jr.
Mr. Richard Conover Henriques, Jr.
Independent Director
Independent Director
--
--
Dr. Gwendolyn Knowlton (Gwen) Binder-Scholl, Ph.D.
Dr. Gwendolyn Knowlton (Gwen) Binder-Scholl, Ph.D.
President - Science and Technology
President - Science and Technology
--
--
Dr. Arun Das, M.D.
Dr. Arun Das, M.D.
Chief Business Officer
Chief Business Officer
--
--
Mr. Anup Marda
Mr. Anup Marda
Chief Financial Officer
Chief Financial Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Steven Nichtberger, M.D.
Dr. Steven Nichtberger, M.D.
Chief Executive Officer, President, Chairman of the Board, Co-Founder
Chief Executive Officer, President, Chairman of the Board, Co-Founder
1.35M
-30.78%
Dr. Scott C. Brun, M.D.
Dr. Scott C. Brun, M.D.
Independent Director
Independent Director
--
--
Dr. David J. Chang, M.D.
Dr. David J. Chang, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Catherine Bollard, M.D.
Dr. Catherine Bollard, M.D.
Independent Director
Independent Director
--
--
Mr. Mark J. Simon
Mr. Mark J. Simon
Independent Director
Independent Director
--
--
Ms. Shawn Cline Tomasello
Ms. Shawn Cline Tomasello
Independent Director
Independent Director
--
--
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 6月24日 周二
更新时间: 6月24日 周二
持股股东
股东类型
持股股东
持股股东
占比
Jennison Associates LLC
6.69%
Citadel Advisors LLC
5.36%
T. Rowe Price Investment Management, Inc.
4.41%
Adage Capital Management, L.P.
4.04%
The Vanguard Group, Inc.
3.84%
Other
75.66%
持股股东
持股股东
占比
Jennison Associates LLC
6.69%
Citadel Advisors LLC
5.36%
T. Rowe Price Investment Management, Inc.
4.41%
Adage Capital Management, L.P.
4.04%
The Vanguard Group, Inc.
3.84%
Other
75.66%
股东类型
持股股东
占比
Investment Advisor
21.50%
Hedge Fund
13.30%
Investment Advisor/Hedge Fund
9.13%
Research Firm
2.25%
Individual Investor
1.68%
Bank and Trust
0.14%
Pension Fund
0.02%
Other
51.98%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
332
43.19M
48.02%
-20.01M
2025Q1
343
38.78M
72.92%
-24.88M
2024Q4
342
40.39M
82.63%
-20.01M
2024Q3
330
50.24M
102.85%
-12.34M
2024Q2
325
53.21M
110.27%
-11.74M
2024Q1
310
53.11M
110.79%
-5.05M
2023Q4
269
50.62M
118.36%
-623.67K
2023Q3
244
42.61M
108.50%
-4.28M
2023Q2
218
38.30M
97.94%
+637.03K
2023Q1
208
26.57M
91.08%
-5.98M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Jennison Associates LLC
2.43M
2.71%
-78.33K
-3.12%
Mar 31, 2025
Citadel Advisors LLC
4.82M
5.36%
+4.82M
+1376631.43%
Jun 12, 2025
T. Rowe Price Investment Management, Inc.
3.97M
4.41%
-103.98K
-2.55%
Mar 31, 2025
Adage Capital Management, L.P.
3.63M
4.04%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
2.84M
3.16%
-23.48K
-0.82%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.11M
3.45%
+57.80K
+1.90%
Mar 31, 2025
Bain Capital Life Sciences Investors, LLC
2.76M
3.07%
--
--
Mar 31, 2025
Schonfeld Strategic Advisors LLC
1.66M
1.85%
+1.66M
--
Mar 31, 2025
Cantor Fitzgerald, L.P
1.48M
1.65%
+1.38M
+1384.59%
Mar 31, 2025
Nichtberger (Steven)
1.35M
1.5%
-600.00K
-30.78%
Apr 28, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares Micro-Cap ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
ProShares UltraPro Russell2000
0%
iShares Russell 2000 ETF
0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0%
iShares Morningstar Small-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
Humankind US Stock ETF
0%
iShares ESG Aware MSCI USA Small-Cap ETF
0%
SPDR Portfolio MSCI Global Stock Market ETF
0%
查看更多
iShares Micro-Cap ETF
占比0.02%
Invesco RAFI US 1500 Small-Mid ETF
占比0.01%
ProShares UltraPro Russell2000
占比0%
iShares Russell 2000 ETF
占比0%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0%
iShares Morningstar Small-Cap ETF
占比0%
iShares Core S&P Total U.S. Stock Market ETF
占比0%
Humankind US Stock ETF
占比0%
iShares ESG Aware MSCI USA Small-Cap ETF
占比0%
SPDR Portfolio MSCI Global Stock Market ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
